Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? A single-center phase 2 study

被引:8
|
作者
Rossi, E
Perrone, F
Labonia, V
Landi, G
Nuzzo, F
Amabile, G
Gridelli, C
Di Maio, M
D'Aiuto, G
de Matteis, A
机构
[1] Natl Canc Inst, Div Med Oncol C, I-80131 Naples, Italy
[2] Natl Canc Inst, Clin Trials Unit, I-80131 Naples, Italy
[3] Civil Hosp, Monteforte, Italy
关键词
D O I
10.1159/000070313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:479 / 480
页数:2
相关论文
共 50 条
  • [41] Efficacy and safety of eribulin plus gemcitabine in second-line or beyond for patients with HER2-negative metastatic breast cancer: A multi-center, open-label, single-arm, phase II study
    Peng, Peijian
    Xu, Xiaolu
    Zhong, Jincai
    Lin, Hong
    Wang, Hong
    Ye, Jin-Hui
    Du, Caiwen
    Wang, Zhi-Hui
    Yu, Gengsheng
    Zou, Guorong
    Ouyang, Jie
    Wang, Yong-Xia
    Li, Lu-Zhen
    Xu, Fei
    Cui, Shi-En
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Capecotabome plus cetuximab as second-line chemotherapy in elderly patients with metastatic colorectal cancer: Results of a phase II study
    Rozzi, A.
    Corona, M.
    Nardoni, C.
    Petricola, F.
    Restuccia, M.
    Lanzetta, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [43] Comparative analysis of the effectiveness of second-line bevacizumab plus chemotherapy in second-line therapy in metastatic colorectal cancer.
    Smagulova, Kaldigul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [44] Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer
    Mariani, G
    Tagliabue, P
    Zucchinelli, P
    Brambilla, C
    Demicheli, R
    Villa, E
    Marchianò, A
    Valagussa, P
    Bonadonna, G
    Gianni, L
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 70 (03) : 163 - 169
  • [45] Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer
    G. Mariani
    P. Tagliabue
    P. Zucchinelli
    C. Brambilla
    R. Demicheli
    E. Villa
    A. Marchianò
    P. Valagussa
    G. Bonadonna
    L. Gianni
    Breast Cancer Research and Treatment, 2001, 70 : 163 - 169
  • [46] Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy
    Gouji Toyokawa
    Mitsuhiro Takenoyama
    Fumihiko Hirai
    Ryo Toyozawa
    Eiko Inamasu
    Miyako Kojo
    Yosuke Morodomi
    Yoshimasa Shiraishi
    Tomoyoshi Takenaka
    Masafumi Yamaguchi
    Mototsugu Shimokawa
    Takashi Seto
    Yukito Ichinose
    International Journal of Clinical Oncology, 2014, 19 : 601 - 606
  • [47] Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy
    Toyokawa, Gouji
    Takenoyama, Mitsuhiro
    Hirai, Fumihiko
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Morodomi, Yosuke
    Shiraishi, Yoshimasa
    Takenaka, Tomoyoshi
    Yamaguchi, Masafumi
    Shimokawa, Mototsugu
    Seto, Takashi
    Ichinose, Yukito
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 601 - 606
  • [48] Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer
    V Lorusso
    E Crucitta
    N Silvestris
    A Catino
    L Caporusso
    A Mazzei
    M Guida
    A Latorre
    D Sambiasi
    C D'Amico
    F Schittulli
    P Calabrese
    M De Lena
    British Journal of Cancer, 2003, 88 : 491 - 495
  • [49] Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancer
    Lorusso, V
    Crucitta, E
    Silvestris, N
    Catino, A
    Caporusso, L
    Mazzei, A
    Guida, M
    Latorre, A
    Sambiasi, D
    D'Amico, C
    Schittulli, F
    Calabrese, P
    De Lena, M
    BRITISH JOURNAL OF CANCER, 2003, 88 (04) : 491 - 495
  • [50] Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial
    Li, Dou-Dou
    Tao, Zhong-hua
    Wang, Bi-Yun
    Wang, Lei-Ping
    Cao, Jun
    Hu, Xi-Chun
    Zhang, Jian
    NPJ BREAST CANCER, 2022, 8 (01)